FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Morra R; Lebray P; Ingiliz P; Ngo Y; Munteanu M; Ratziu V; Poynard T

doi:10.1002/hep.22046

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M …

MeSH — NLM indexing Aspartate Aminotransferases / blood Biomarkers / blood Hepatitis C, Chronic / complications Humans Liver Cirrhosis / blood Liver Cirrhosis / diagnosis Liver Cirrhosis / virology Platelet Count Prognosis

Acciones del personal

Descargar PDF

Los archivos son para uso autorizado únicamente en los canales asociados de BioPredictive.

Fibrotest Actitest Letter Our Group France

Autores (7)

Cita

Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M, Ratziu V, et al. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C. Hepatology. 2008;47(1):353-4; author reply 354-6. doi:10.1002/hep.22046.

Identificadores

DOI: 10.1002/hep.22046
PMID: 18161711

Pruebas

Enfermedades hepáticas

Lesiones hepáticas

Comparaciones

Temas

Poblaciones de pacientes

Región

Carrito

Su carrito está vacío.

Explore las publicaciones y use Añadir al carrito en cualquier página de detalle para crear un archivo ZIP que pueda enviar a los clientes.

Explorar las publicaciones

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Más de Morra R

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

FibroMAX: towards a new universal biomarker of liver disease?

Más sobre el mismo tema

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.